<DOC>
	<DOC>NCT00015171</DOC>
	<brief_summary>The purpose of this study is the use of buprenorphine/naloxone in treatment of opioid dependence.</brief_summary>
	<brief_title>Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1</brief_title>
	<detailed_description>The objective of this study is to determine the safety and efficacy of a buprenorphine/naloxone combination tablet for opiate dependence treatment.</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine, Naloxone Drug Combination</mesh_term>
	<criteria>DSMIV diagnosis of current opiate dependence males and nonpregnant, nonnursing female 1859 yrs of age Any significant medical condition AST or ALT levels greater than 3x's the upper limit of normal level Current Axis I diagnosis other than opiate, caffeine or nicotine dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>January 1999</verification_date>
	<keyword>opioid dependence</keyword>
</DOC>